Brighton Jones LLC’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,391
Closed -$535K 330
2019
Q3
$535K Sell
5,391
-492
-8% -$46.8K 0.06% 162
2019
Q2
$544K Buy
5,883
+143
+2% +$13.6K 0.06% 162
2019
Q1
$541K Sell
5,740
-1,739
-23% -$152K 0.07% 159
2018
Q4
$479K Sell
7,479
-22
-0.3% -$1.62K 0.07% 149
2018
Q3
$671K Buy
7,501
+11
+0.1% +$972 0.08% 124
2018
Q2
$595K Buy
7,490
+40
+0.5% +$3.32K 0.08% 151
2018
Q1
$665K Sell
7,450
-189
-2% -$18.1K 0.09% 124
2017
Q4
$797K Sell
7,639
-120
-2% -$13.5K 0.1% 106
2017
Q3
$1.13M Sell
7,759
-38
-0.5% -$5.18K 0.15% 83
2017
Q2
$1.01M Buy
7,797
+242
+3% +$29.7K 0.14% 86
2017
Q1
$940K Buy
+7,555
New +$904K 0.23% 37
2016
Q4
Sell
-7,187
Closed -$751K 232
2016
Q3
$751K Sell
7,187
-39
-0.5% -$4.22K 0.12% 97
2016
Q2
$713K Sell
7,226
-167
-2% -$17.3K 0.13% 94
2016
Q1
$740K Buy
7,393
+121
+2% +$12.5K 0.14% 91
2015
Q4
$871K Buy
7,272
+27
+0.4% +$3.12K 0.17% 76
2015
Q3
$784K Buy
7,245
+52
+0.7% +$6.45K 0.17% 71
2015
Q2
$832K Buy
7,193
+50
+0.7% +$5.72K 0.19% 62
2015
Q1
$823K Buy
7,143
+8
+0.1% +$956 0.19% 57
2014
Q4
$798K Buy
7,135
+428
+6% +$45.1K 0.18% 62
2014
Q3
$636K Buy
6,707
+49
+0.7% +$4.42K 0.14% 81
2014
Q2
$572K Buy
6,658
+64
+1% +$4.87K 0.13% 87
2014
Q1
$460K Sell
6,594
-18
-0.3% -$1.43K 0.11% 101
2013
Q4
$559K Buy
6,612
+780
+13% +$61.7K 0.13% 85
2013
Q3
$449K Hold
5,832
0.12% 84
2013
Q2
$341K Buy
+5,832
New +$351K 0.1% 76

Other funds holding CELG

Brighton Jones LLC's CELG Position: Q4 2019 in Review

Brighton Jones LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,391 shares — an estimated $535K sold.

Brighton Jones LLC first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $1.13M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brighton Jones LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brighton Jones LLC sold 5,391 Celgene Corp shares in Q4 2019, an estimated $535K.
  • Brighton Jones LLC first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Brighton Jones LLC's Celgene Corp position peaked at $1.13M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brighton Jones LLC's 13F filing for Q4 2019, filed 7 Feb 2020.